Cargando…

The impact of Highly Active Antiretroviral Therapy (HAART) on the clinical features of HIV - related oral lesions in Nigeria

BACKGROUND: This study aimed to determine the therapeutic effects of highly active anti-retroviral therapy (HAART) on the clinical presentations of HIV related oral lesions (HIV-ROLs) in an adult Nigerian population. METHODS: A 5 month prospective study on HAART naïve HIV positive adults recruited i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taiwo, Olaniyi O, Hassan, Zuwaira
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903493/ https://www.ncbi.nlm.nih.gov/pubmed/20579347 http://dx.doi.org/10.1186/1742-6405-7-19

Ejemplares similares

Oral lesions among HIV seropositive individuals in an era of generic HAART: markers of HAART efficacy?
por: Vasudevan, Janani, et al.
Publicado: (2012)

Orofacial lesions associated with long-term highly active antiretroviral therapy among HIV-seropositive adults in Ibadan, Nigeria
por: Abe, Oluwatoyin Elizabeth, et al.
Publicado: (2021)

Tolerability of antiretroviral therapy (HAART) in elderly age
por: Celesia, B M
Publicado: (2010)

Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda
por: Alibhai, Arif, et al.
Publicado: (2010)

Modification of Initial Highly Active Antiretroviral Therapy (HAART) Regimen in Paediatric HIV Patients
por: Low, Yee Shan, et al.
Publicado: (2018)

Post-consent assessment of dental subjects' understanding of informed consent in oral health research in Nigeria
por: Taiwo, Olaniyi O, et al.
Publicado: (2009)

Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon
por: Dimala, Christian Akem, et al.
Publicado: (2016)

Hypertension among HIV-Infected Adults Receiving Highly Active Antiretroviral Therapy (HAART) in Malaysia
por: Hejazi, Nazisa, et al.
Publicado: (2014)

Risks of cardio-vascular diseases among highly active antiretroviral therapy (HAART) treated HIV seropositive volunteers at a treatment centre in Lagos, Nigeria
por: Ekun, Oloruntoba Ayodele, et al.
Publicado: (2021)

A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon
por: Dimala, Christian Akem, et al.
Publicado: (2016)

Interventions to promote adherence to Antiretroviral Therapy (HAART) among adult patients at an HIV/AIDS program in Uganda
por: Muhumuza, Simon, et al.
Publicado: (2010)

Neurobehavioral Effects in HIV-Positive Individuals Receiving Highly Active Antiretroviral Therapy (HAART) in Gaborone, Botswana
por: Lawler, Kathy, et al.
Publicado: (2011)

Craniofacial morphology of HIV-infected adolescents undergoing highly active antiretroviral therapy (HAART): An original research
por: Neeraja, M., et al.
Publicado: (2020)

Impact of vitamin supplements on HAART related hematological abnormalities in HIV-infected patients
por: Rezaei, Esmaeil, et al.
Publicado: (2016)

Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART)
por: Dold, Leona, et al.
Publicado: (2015)

Prevalence of HIV related oral lesions in people living with HIV and on combined antiretroviral therapy: a Nigerian experience
por: Mary, Eweka Olutola, et al.
Publicado: (2018)

Relationship of ethnicity and CD4 Count with glucose metabolism among HIV patients on Highly-Active Antiretroviral Therapy (HAART)
por: Misra, Ranjita, et al.
Publicado: (2013)

Tissue viral dynamics in SIV infected macaques with highly active antiretroviral therapy (HAART)
por: Bourry, Olivier, et al.
Publicado: (2009)

The Potential of Spirulina platensis to Ameliorate the Adverse Effects of Highly Active Antiretroviral Therapy (HAART)
por: Sibiya, Thabani, et al.
Publicado: (2022)

HIV and HAART-Associated Dyslipidemia
por: Feeney, Eoin R, et al.
Publicado: (2011)

Significant effect of HIV/HAART on oral microbiota using multivariate analysis
por: Griffen, Ann L., et al.
Publicado: (2019)

Ophthalmic manifestations of human immunodeficiency virus infection: Pre- highly active antiretroviral chemotherapy (HAART) and post- HAART era
por: Sinha, Rajesh, et al.
Publicado: (2008)

HIV-associated primary lung cancer (LC) in the era of highly active antiretroviral therapy (HAART): a multi-institutional collaboration
por: D’Jaen, Gabriela, et al.
Publicado: (2010)

Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
por: Ngemu, Erastus K, et al.
Publicado: (2014)

Association between highly active antiretroviral therapy (HAART) and hypertension in persons living with HIV/AIDS at the Bamenda regional hospital, Cameroon
por: Pangmekeh, Pepanze Jill, et al.
Publicado: (2019)

Mutations Related to Antiretroviral Resistance Identified by Ultra-Deep Sequencing in HIV-1 Infected Children under Structured Interruptions of HAART
por: Vazquez-Guillen, Jose Manuel, et al.
Publicado: (2016)

Chest X-ray findings in HIV- infected Highly Active Antiretroviral Treatment (HAART)-naïve patients
por: Akinbami, Akinsegun, et al.
Publicado: (2012)

Impact of HAART Therapy and HIV Infection over Fetal Growth—An Anthropometric Point of View
por: Matasariu, Daniela Roxana, et al.
Publicado: (2022)

Immuno-virological response and clinical outcome in naive elderly patients treated with antiretroviral therapy (HAART)
por: Bisicchia, F, et al.
Publicado: (2010)

Prevalence of Depressive Symptoms Amongst Highly Active Antiretroviral Therapy (HAART) Patients in AIDSRelief Uganda
por: Shumba, Constance, et al.
Publicado: (2013)

Preference for complementary and alternative medicine among patients on long-term treatment in Jos university teaching hospital, Nigeria
por: Afolaranmi, Tolulope O., et al.
Publicado: (2020)

Clinical Features, Treatment, and Outcome of HIV-Associated Immune Thrombocytopenia in the HAART Era
por: Ambler, Kimberley L. S., et al.
Publicado: (2012)

The Impact of HIV on Maternal Morbidity in the Pre-HAART Era in Uganda
por: Nuwagaba-Biribonwoha, Harriet, et al.
Publicado: (2012)

1592 Impact of HAART on Incidence of Primary HIV-Associated Thrombocytopenia
por: O'bryan, Thomas, et al.
Publicado: (2014)

A Real-world Evidence-based Management of HIV by Differential Duration HAART Treatment and its Association with Incidence of Oral Lesions
por: Shu, Wen, et al.
Publicado: (2022)

Estimating the cost to rural ambulating HIV/AIDS patients on Highly Active Antiretroviral Therapy (HAART) in rural Ghana: a pilot study
por: Apanga, Stephen, et al.
Publicado: (2012)

Plasma Mitochondrial DNA Levels as a Biomarker of Lipodystrophy Among HIV-Infected Patients Treated with Highly Active Antiretroviral Therapy (HAART)
por: Dai, Z., et al.
Publicado: (2015)

Effect of highly active antiretroviral therapy (HAART) on some specific clotting profile in Human Immunodeficiency Virus -(HIV) positive pregnant women
por: Evarista, Osime Odaburhine, et al.
Publicado: (2020)

Prevalence of HPV in the oral cavity of HIV seropositive Indian women undergoing HAART
por: Mukherjee, Jaya, et al.
Publicado: (2014)

The Knowledge and Uptake of Travel Vaccine Among Medical Doctors in a Tertiary Health Institution in Plateau State, North Central Nigeria
por: Hassan, Zuwaira Ibrahim, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nj9p70k3tqiu1aqqnq8hr62s2m